| Related LncRNAs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
| EL0332 | DBET | Facioscapulohumeral muscular dystrophy | Gene expression study in human cells to build pathways involved by DBE-T in FSHD patients | N/A | N/A | N/A | DBE-T, a chromatin-associated noncoding RNA produced selectively in FSHD patients that coordinates de-repression of 4q35 genes. DBE-T recruits the Trithorax group protein Ash1L to the FSHD locus, driving histone H3 lysine 36 dimethylation, chromatin remodeling, and 4q35 gene transcription. | 22541069 | |
| EL0332 | DBET | Facioscapulohumeral muscular dystrophy | N/A | N/A | N/A | mutation | The activatory long non-coding RNA DBE-T reveals the epigenetic etiology of facioscapulohumeral muscular dystrophy. | 22710800 | LncRNADisease |
| EL0332 | DBET | Facioscapulohumeral muscular dystrophy | N/A | N/A | N/A | regulation | Epigenetic deregulation of lncRNAs genes is associated with disease | 23791884 | LncRNADisease |
| EL0332 | DBET | Facioscapulohumeral muscular dystrophy | N/A | N/A | N/A | regulation | In contrast, in FSHD patients, a deletion of D4Z4 repeats results in cis production of the DBE-T lncRNA that binds to protein complexes, reorganizes the chromatin state of the FSHD locus, and reactivates the repressed 4q35 genes. | 24667321 | LncRNADisease |
| EL0332 | DBET | Facioscapulohumeral muscular dystrophy | N/A | N/A | N/A | expression | As a result, this region becomes more prone to transcription and gives rise to the activatory lncRNA DBE-T. DBE-T is mainly produced in FSHD patients and mediates the aberrant activation of the FSHD locus. | 24685002 | LncRNADisease |